High-dose cytosine arabinoside and etoposide with total body irradiation as a preparatory regimen for allogeneic hematopoietic stem-cell transplantation in patients with acute lymphoblastic leukemia

Bone Marrow Transplantation

Volumn 34, Issue 4, 2004, Pages 299-303

  Sato, N ^a   Furukawa, Tatsouf ^b   Kuroha, T ^a   Hashimoto, S ^b   Masuko, M ^a   Takahashi, H ^a   Yano, T ^a   Abe, T ^a   Fuse, I ^b   Koike, T ^c   Kishi, K ^d   Aizawa, Y ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c NAGAOKA RED CROSS HOSPITAL   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute lymphoblastic leukemia; Cytosine arabinoside; Etoposide; Hematopoietic stem cell transplantation; Total body irradiation

Indexed keywords

ANTIEMETIC AGENT; CORTICOSTEROID; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HEPARIN; METHOTREXATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BLADDER DISEASE; CANCER PATIENT; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; FEASIBILITY STUDY; FEMALE; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; HEART DISEASE; HUMAN; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; MALE; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; STOMATITIS; TREATMENT OUTCOME; VEIN OCCLUSION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHILD; CYTARABINE; ETOPOSIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIBLINGS; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 4444286421     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704575     Document Type: Article

References (23)

1. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998; 339: 605-615.
2. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood 1995; 85: 1151-1168.
3. Barrett J. Adult acute lymphoblastic leukaemia. In: Barrett J and Treleaven J (eds.). The Clinical Practice of Stem-Cell Transplantation. Isis Medical Media: Oxford, UK, 1998; pp 63-82.
4. Bearman SI, Appelbaum FR, Buckner CD et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562-1568.
5. CTEP, NCI: Common Toxicity Criteria Manual, version 2.0. National Cancer Institute: Bethesda, MD, 1999; pp 1-35.
6. Blume KG, Forman SJ, O'Donnell MR et al. Total body irradiation and high-dose etoposide: a new preparatory regimen for bone marrow transplantation in patients with advanced hematologic malignancies. Blood 1987; 69: 1015-1020.
7. Schmitz N, Gassmann W, Johannson W et al. Fractionated total body irradiation and high-dose VP 16-213 followed by allogeneic bone marrow transplantation in advanced leukemias. Blood 1988; 72: 1567-1573.
8. Snyder DS, Chao NJ, Amylon MD et al. Fractionated total body irradiation and high-dose etoposide as a preparatory regimen for bone marrow transplantation for 99 patients with acute leukemia in first complete remission. Blood 1993; 82: 2920-2928.
9. Herzig RH, Wolf SN, Lazarus HM et al. High-dose cytosine arabinoside therapy for refractory leukemia. Blood 1983; 62: 361-369.
10. Rohatiner AZS, Bassan R, Battista R et al. High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemia. Br J Cancer 1990; 62: 454-458.
11. Herzig RH, Coccia PF, Lazarus HM et al. Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation. Semin Oncol 1985; 12: 184-186.
12. Weyman C, Graham-Pole J, Emerson S et al. Use of cytosine arabinoside and total irradiation as conditioning for allogeneic marrow transplantation in patients with acute lymphoblastic leukemia: a multicenter survey. Bone Marrow Transplant 1993; 11: 43-50.
13. Andersson BS, Luna MA, Yee C et al. Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia. Cancer 1990; 65: 1079-1084.
14. Coccia PF, Strandjord SE, Warkentin PI et al. High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission. Blood 1988; 71: 888-893.
15. Woods WG, Ramsay NK, Weisdorf DJ et al. Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens. Bone Marrow Transplant 1990; 6: 9-16.
16. Gordon BG, Warkentin PI, Strandjord SE et al. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Bone Marrow Transplant 1997; 20: 5-10.
17. Kumar M, Saleh A, Rao PV et al. Toxicity associated with high-dose cytosine arabinoside and total body irradiation as conditioning for allogeneic bone marrow transplantation. Bone Marrow Transplant 1997; 19: 1061-1064.
18. Weisdorf DJ, Nesbit ME, Ramsay NKC et al. Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease. J Clin Oncol 1987; 5: 1348-1355.
19. Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
20. Doney K, Fisher LD, Appelbaum FR et al. Teatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival. Bone Marrow Transplant 1991; 7: 453-459.
21. Appelbaum FR. Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL). Leukemia 1997; 11: S15-S17.
22. Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041-2050.
23. Collins Jr RH, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-444.